#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Rett syndrome Amyotrophic lateral sclerosis gene carrier Exudative retinopathy Cardiac sarcoidosis Myeloid leukaemia Primary amyloidosis Hidradenitis Fusarium infection Encephalitis autoimmune Thromboangiitis obliterans Oesophageal squamous cell carcinoma stage II Dupuytren's contracture Transitional cell carcinoma Peritoneal neoplasm Osteochondrodysplasia More trials…

    Learn about Rare Diseases

    Primary hyperoxaluria – Trials in Disease Pituitary-dependent Cushing’s syndrome – Basic Information Leukoencephalopathy Ornithine transcarbamoylase deficiency – Trials in Disease Congenital generalised lipodystrophy – Diagnostics Mucopolysaccharidosis – Basic Information Primary mediastinal large B-cell lymphoma – Diagnostics Pelizaeus-Merzbacher disease – Basic Information Brain stem glioma – Life with Disease Hairy cell leukaemia recurrent – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Talquetamab Tamoxifen Clobetasol Glepaglutide Cefuroxime Human Serum Albumin 5% Anb032 Carbetocin Omeprazole Bexotegrast Mosaic Hbcoreag Amsacrine Polatuzumab Vedotin ULTEVURSEN CICLOPIROX Tetracaine Hydrochloride Mepacrine Regn7257 YOHIMBINE HYDROCHLORIDE Amb-05X More therapies…

    Learn about Your Condition

    EGFR gene mutation Liver transplant White matter lesion Colitis Lichen planus Hyponatraemia Sickle cell disease Indolent systemic mastocytosis Cholangiosarcoma Biliary tract operation Gestational diabetes Type 2 diabetes mellitus Meniscus operation Stomatitis Candida infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Estonia

  • A study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis

    Recruiting

    3 1
    Investigated Diseases:
    • Secondary progressive multiple sclerosis
    Investigated Drugs:
    • Remibrutinib
    Austria Belgium Bulgaria Croatia Czechia Denmark +19
  • A Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Human Normal Immunoglobulin (Iv)
    • Empasiprubart
    Austria Bulgaria Czechia Denmark Estonia France +13
  • A study of bleximenib combined with intensive chemotherapy for adults with newly diagnosed acute myeloid leukemia with specific genetic changes.

    Recruiting

    3 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • BLEXIMENIB
    Austria Belgium Denmark Estonia Finland Germany +8
  • A Study of IMVT-1402 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy to Prevent Disease Relapse

    Recruiting

    2 1
    Investigated Diseases:
    • Chronic inflammatory demyelinating polyradiculoneuropathy
    Investigated Drugs:
    • IMEROPRUBART
    Austria Belgium Bulgaria Denmark Estonia Finland +13
  • Study comparing daratumumab, lenalidomide and dexamethasone followed by linvoseltamab versus continued initial treatment in newly diagnosed multiple myeloma patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Linvoseltamab
    • Daratumumab
    • Dexamethasone
    Austria Belgium Croatia Czechia Denmark Estonia +10
  • Safety and Tolerability Study of NBI-1065845 as Additional Treatment for Adults with Major Depressive Disorder

    Recruiting

    3 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • 9-(4-CYCLOHEXYLOXYPHENYL)-7-METHYL-3,4-DIHYDROPYRAZINO[2,1-C][1,2,4]THIADIAZINE 2,2-DIOXIDE
    Belgium Bulgaria Croatia Czechia Estonia Finland +10
Previous Page
1 2 3 4 5 … 30
Next Page

Find Clinical Trials in Your Selected Region and City

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Pembrolizumab Cisplatin Dexamethasone Fluorouracil Hydrocortisone Prednisolone Risankizumab Oxaliplatin Cytarabine Upadacitinib Inclisiran Venetoclax Etoposide Tocilizumab Carboplatin Olaparib Prednisone Durvalumab Pneumococcal Polysaccharide Serotype 9N Pneumococcal Polysaccharide Serotype 1 Aflibercept Pneumococcal Polysaccharide Serotype 9V Pneumococcal Polysaccharide Serotype 10A Pneumococcal Polysaccharide Serotype 22F Pneumococcal Polysaccharide Serotype 11A Rosuvastatin Pneumococcal Polysaccharide Serotype 23F Pneumococcal Polysaccharide Serotype 12F Pneumococcal Polysaccharide Serotype 3 GSKVX000000025896 Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acromegaly Acute coronary syndrome Acute kidney injury Acute lymphocytic leukaemia Acute myeloid leukaemia Acute myocardial infarction Adenocarcinoma gastric Adenocarcinoma of colon Adrenogenital syndrome Age-related macular degeneration Arteriosclerosis Atrial fibrillation Axial spondyloarthritis Bladder cancer Cardiac failure Cardiovascular disorder Cerebrovascular accident prophylaxis Chronic inflammatory demyelinating polyradiculoneuropathy Chronic kidney disease Chronic lymphocytic leukaemia Chronic obstructive pulmonary disease Chronic rhinosinusitis with nasal polyps Coagulation factor X level Colitis ulcerative Colorectal cancer metastatic Colorectal cancer stage IV Coronary artery disease Critical illness Crohn's disease Cytomegalovirus immunisation Dementia Alzheimer's type Dermatitis atopic Diabetic foot infection Diffuse large B-cell lymphoma Diffuse large B-cell lymphoma refractory Dyslipidaemia Emphysema Encephalopathy neonatal Endocrine ophthalmopathy Endometrial cancer Factor IX deficiency Factor VIII deficiency Focal segmental glomerulosclerosis Follicular lymphoma Gastric cancer Generalised anxiety disorder Glioblastoma multiforme Hepatocellular carcinoma Herpes simplex Herpes zoster Hormone-refractory prostate cancer Hypercholesterolaemia Idiopathic pulmonary fibrosis IgA nephropathy Influenza Influenza immunisation Interstitial lung disease Lupus nephritis Macular oedema Major depression Mantle cell lymphoma Metapneumovirus infection Metastatic malignant melanoma Microsatellite instability cancer Multifocal motor neuropathy Multiple sclerosis Multiple sclerosis relapse Myelodysplastic syndrome Neonatal asphyxia Neoplasm Neoplasm malignant Neovascular age-related macular degeneration Nephropathy Non-small cell lung cancer Non-small cell lung cancer metastatic Non-small cell lung cancer stage II Non-small cell lung cancer stage III Non-small cell lung cancer stage IIIA Non-small cell lung cancer stage IIIB Obesity Oesophageal adenocarcinoma Oesophageal carcinoma Orthostatic hypotension Osteoarthritis Osteoporosis postmenopausal Overweight Paroxysmal nocturnal haemoglobinuria PD-L1 positive cancer Plasma cell myeloma Plasma cell myeloma refractory Pneumococcal immunisation Pneumonia Pneumonia respiratory syncytial viral Primary biliary cholangitis Primary progressive multiple sclerosis Progressive relapsing multiple sclerosis Prophylaxis of nausea and vomiting Prostate cancer Prostate cancer recurrent Psoriasis Psoriatic arthropathy Pyelonephritis acute Relapsing multiple sclerosis Relapsing-remitting multiple sclerosis Renal disorder Respiratory syncytial virus bronchiolitis Respiratory syncytial virus bronchitis Respiratory syncytial virus infection Retinal vein occlusion Rheumatoid arthritis Richter's syndrome Secondary progressive multiple sclerosis Sjogren's syndrome Small cell lung cancer Small cell lung cancer extensive stage Small cell lung cancer limited stage Systemic lupus erythematosus Thrombosis prophylaxis Type 1 diabetes mellitus Urinary tract infection Varicella

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!